All that bleeds is not infliximab-refractory ulcerative colitis

J. K. Law, B. Salh, E. M. Yoshida

Research output: Contribution to journalArticle

Abstract

The role of biological agents in moderate to severe ulcerative colitis has been shown to be effective in the induction of clinical remission, However, the role of infliximab therapy for induction of remission in patients with fulminant colitis is debatable. A case of a hospitalized patient with a new diagnosis of severe ulcerative coliris refractory to intravenous steroids is presented. The patient was treated with infliximab and discharged with clinical remission, but subsequently presented back to hospital with a lower gastrointestinal hemorrhage.

Original languageEnglish (US)
Pages (from-to)91-92
Number of pages2
JournalCanadian Journal of Gastroenterology
Volume23
Issue number2
DOIs
StatePublished - Jan 1 2009

Keywords

  • Infliximab
  • Severe colitis

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'All that bleeds is not infliximab-refractory ulcerative colitis'. Together they form a unique fingerprint.

  • Cite this